<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cyclooxygenase-2 is overexpressed in the majority of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumours</z:e> leading to elevated levels of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E(2) (<z:chebi fb="0" ids="26338">PGE</z:chebi>(2)), promoting many hallmarks of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Importantly, <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) is reported to enhance Wnt/Î²-catenin signalling in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells and in <z:mpath ids='MPATH_458'>normal</z:mpath> haematopoietic stem cells where it promotes stem cell function </plain></SENT>
<SENT sid="2" pm="."><plain>Although Wnt signalling plays a crucial role in intestinal stem cells, the relationship between <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) and intestinal stem cells is unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Given that the key <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancer</z:e> stem cell marker LGR5 (leucine-rich G-protein coupled receptor 5) is a Wnt target and <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) enhances Wnt signalling, the focus of this study was to investigate whether <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) regulated LGR5 expression in colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> cells and whether LGR5 was important for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell survival </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="26338">PGE</z:chebi>(2) upregulated LGR5 protein in <z:mpath ids='MPATH_270'>adenoma</z:mpath> (RG/C2) and <z:mp ids='MP_0002038'>carcinoma</z:mp> (DLD-1) cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>LGR5 knockdown induced cell <z:hpo ids='HP_0011420'>death</z:hpo> in RG/C2 and AA/C1 <z:mpath ids='MPATH_270'>adenoma</z:mpath> cells, suggesting that LGR5 has an important survival-promoting role in <z:mpath ids='MPATH_270'>adenoma</z:mpath> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Indeed, we detected LGR5 protein expression in 4 of 4 human <z:mpath ids='MPATH_270'>adenoma</z:mpath> cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, LGR5 small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> inhibited the survival-promoting effects of <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) in RG/C2, suggesting that <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) promotes <z:mpath ids='MPATH_270'>adenoma</z:mpath> cell survival, at least in part, by increasing LGR5 expression </plain></SENT>
<SENT sid="8" pm="."><plain>These studies, therefore, show the first link between <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) and LGR5 in human colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:mp ids='MP_0002038'>carcinoma</z:mp> cells and demonstrate a survival-promoting role of LGR5 </plain></SENT>
<SENT sid="9" pm="."><plain>As <z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>) cause <z:mpath ids='MPATH_270'>adenomas</z:mpath> to regress in FAP patients, these studies could have important implications for the mechanism by which <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> are chemopreventive, as lowering <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) levels could reduce LGR5 expression and survival of LGR5(+) <z:mpath ids='MPATH_270'>adenoma</z:mpath> stem cells </plain></SENT>
</text></document>